Benefit-harm analysis and charts for individualized and preference-sensitive prevention: example of low dose aspirin for primary prevention of cardiovascular disease and cancer
2019 ◽
Vol 8
(24)
◽
2003 ◽
Vol 03
(2)
◽
pp. 177-184
◽
2005 ◽
Vol 352
(13)
◽
pp. 1293-1304
◽
2005 ◽
Vol 60
(8)
◽
pp. 519-521
◽
2006 ◽
Vol 2006
◽
pp. 23-25
2018 ◽
Vol 71
(11)
◽
pp. A1892
◽